JamesAUnderbergMDMS, FACP, FACPM, FNLA

PubMed

• 42 citations
  Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evalu...
  James A. Underberg, Christopher P. Cannon, Dominique Larrey, Lukas Makris, Dirk J. Blom
  Journal of Clinical Lipidology. 2020-08-19
• 32 citations
  LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design.
  Dirk J. Blom, Zahi A. Fayad, John J.P. Kastelein, Dominique Larrey, Lukas Makris
  Journal of Clinical Lipidology. 2016-03-01
• 18 citations
  LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals.
  James Underberg, Peter P Toth, Fatima Rodriguez
  Postgraduate Medicine. 2022-11-01

Journal Articles

• Lowering LDL‐Cholesterol and CV Benefits: Is There a Limit to How Low LDL‐C Needs to Be for Optimal Health Benefits?  
  Anish Vani, James A Underberg, Clinical Pharmacology & Therapeutics
• A Successful Attempt to Lobby a Hospital Pharmacy and Therapeutics Committee for the Use of Ezetimibe in the Management of Patients with Familial Hypercholesterolemia.  
  Lisa Cioce, MD, Lana Borno, PharmD, BCPS, Vanessa Milne, NP, James Underberg, MS, Journal of Clinical Lipidology 05/2012; 6(3):266
• Discordance in Low-Density Lipoprotein Particle Number (LDL-P) and Apolipoprotein B (Apo B) Level.  
  Pamela Morris, Narinder Bhalla, Kellie Mclain, Hector Malave, James Underberg, Ralph Joe Teague, Hollye Garner, Deborah, Winegar, Ray Pourfarzib, Journal of the American College of Cardiology. March 2013; 61(10);E1360
• Suboptimal Risk Factor Control in Patients Undergoing Elective Cardiovascular Intervention.  
  Lisa Tully, Eugenia Gianos, Anish Vani, Yu Guo, Revathi Balakrishnan, Omad Ullah, Michael Schloss, Arthur Schwartzbard, James Slater, Richard Stein, James Underberg, H..., Journal of the American College of Cardiology. March 2013; 61(10);E1457
• Are Improvements in Lipid Parameters after Gastric Banding Durable in the Long-Term: Five Years of Follow-Up.  
  Amita Singh, Sean Heffron, Jonathan Zagzag, Heekoung Youn, George Fielding, Christine Ren-Fielding, James Underberg, Journal of the American College of Cardiology. March 2013; 61(10);E1426
• Gatric Banding Resolves Metabolic Syndrome in Obese Subjects over Five Years of Follow-Up.  
  Sean Heffron, Amita Singh, Johnathan Zagzag, Heekoung A. Youn, James Underberg, George A. Fielding, Christine J. Ren, Journal of the American College of Cardiology. March 2013; 61(10);E1342
• Does Bariatric Surgery Ameliorate the Dyslipidemia of Obesity? Observations from Five Years of Follow-UP After Gastric Banding.  
  Amita Singh, Sean Heffron, Jonathan Zagzag, Heekoung Youn, George Fielding, Christine Ren-Fielding, James Underberg, Journal of the American College of Cardiology. March 2013; 61(10);1388
• Therapeutic Strategies for Optimizing Outcomes in the Severe Familial Hypercholesterolemia Patient.  
  Underberg JA, Journal of Clinical Lipidology 11/2012; 6(6)
• Attainment of Risk Factor Modification Goals in Patients Undergoing Percutaneous Cardiovascular Interventions.  
  Eugenia Gianos, MD, Lourdes Gonzalez-Santos, Anish Vani, Lisa Cioce, Michael Schloss, Arthur Schwartzbard, Howard Weintraub, James Underberg, Edward Fisher, Jeffery Be..., Journal of Clinical Lipidology 05/2012; 6(3):258
• Electronic Chart Review of A Multispecialty Internal Medicine Practice Evaluating Appropriate Identification of Patients with Familial Hyperlipidemia.  
  Lourdes Ella Gonzalez Santos, MD, James Underberg, Journal of Clinical Lipidology 05/2012; 5(3):229
• The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia  
  Roda Plakogiannis, Lisa Cioce, Edward A Fisher & James A Underberg, Clinical Investigation
• The role of mipomersen therapy in the treatment of familial hypercholesterolemia.  
  Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg, Clinical Investigation. 01/2012; 2(2):1022-1037
• Bridging the gap in treatment options for patients with hypertriglyceridemia.  
  James A Underberg, Richard Hays, The Journal of family practice 01/2008; 56(12 Suppl New):S24-31
• Utility of Different Lipid Measures to Predict Coronary Heart Disease.  
  Remick, J, Underberg JA, Shah N, JAMA, January 2, 2008; 299: 35 – 36
• Hypertension and Dyslipidemia: A Rigadoon.  
  Underberg, JA, Lipid Spin 2009 ;2: 11
• Primary Prevention of Cardiovascular Disease: The Opportunity To Be Superior  
  Underberg, JA, Primary Care Quarterly 2007: 2: 7-8
• Targeting High-Density Lipoprotein Cholesterol in Diabetic Patients to Reduce Cardiovascular Risk.  
  Underberg, JA , Shah, NR, Journal of Clinical Outcomes Management 2007;14: 486-487
• A Suggested Protocol Statin Use by Women Child Bearing Age.  
  Underberg, JA, Lipid Spin 2006;(3):6-8
• Therapeutic Strategies for Optimizing Outcomes in the Severe Familial Hypercholesterolemia Patient  
  James A. Underberg, MD, MS, FNLA, Journal of Clinical Lipidology
• Join now to see all

Books/Book Chapters

• Case Studies in Lipid Management. 
  Chapter: Case Study: Women and Cardiovascular Risk 
  Page 19 - 22Underberg, JABetteridge ed. Informa Healthcare

Abstracts/Posters

• Establishing a HMG-CoA Reductase Inhibitor (Statin) Protocol for Informed Consent in Women of Child Bearing Age.
  Underberg, JA, National Lipid Association Annual Meeting 2006
• Electronic Chart Review of A Multispecialty Internal Medicine Practice Evaluating Appropriate Identification of Patients with Familial Hyperlipidemia.
  Gonzalez-Santos LE, Underberg, J, Journal of Clinical Lipidology Vol. 5, Issue 3, Page 229
• Menopause Practice: A Clinicians Guide.
  Underberg, JA, North American Menopause Society 2007

Lectures

• Understanding the Spectrum of LDL-C in CV Disease: A Focus on Low LDL 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• National Lipid Association(NLA) Clinical Lipid Update – Fall 2013 
  National Lipid Association, Baltimore, Maryland - 9/20/2013
• Lipid Academy - Ancillary Course Info 
  National Lipid Association, Baltimore, Maryland - 9/19/2013
• Outpatient Treatment of Community Acquired Pneumonia; Erectile Dysfunction; Diagnosis and Treatment in the Primary Care Setting; Dyslipidemia and Residual Cardiovascul... 
  Primed Institute, 2004, 2005, 2006, 2007, 2008
• Advanced Lipid Testing. 
  National Lipid Association Annual Meeting
• Preventive Cardiovascular Medicine. 
  American College of Preventive Medicine Annual Meeting, 2006
• Dyslipidemia and the Role of LDL Particles in Cardiovascular Risk Assessment. 
  Lifecare Institute
• Triglycerides and Residual Cardiovascular Risk. 
  Southwestern Lipid Association Regional Meeting
• Hypertension and Dyslipidemia: A Ragadoon. 
  Heartwise Symposium, Lancaster, Pennsylvania, 2008
• Join now to see all